The analyses revealed that the Mef2c-driven group differs from other subtypes in that it displays: (1) fewer CISs, which is also true in sample-size-matched analyses (Figures S16A and S16B) and (2) reduced numbers of total insertions per tumor (Figures 6I and S16C). The gene discussed is MEF2C; the disease is neoplasm.